Erin N. Kane - 06 May 2026 Form 4 Insider Report for Chemours Co (CC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 May 2026, 16:15:09 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eric Stein, Attorney-in-Fact

Key filing fact

Erin N. Kane filed Form 4 for Chemours Co (CC) on 08 May 2026.

Key facts

  • This page summarizes Erin N. Kane's Form 4 filing for Chemours Co (CC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 May 2026, 16:15.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001684077 Primary reporting owner

Kane Erin N

Relationship
Director
Address
C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON
Signature
/s/ Eric Stein, Attorney-in-Fact
Signature date
08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Award

Transaction value
Shares
+7,182
Change %
+11%
Price
$0.000000*
Shares after
74,063
Date
06 May 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.

Footnote F2

Includes deferred stock units and dividend equivalent units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .